Literature DB >> 18379051

Differential regulations of quercetin and its glycosides on ligand-gated ion channels.

Byung-Hwan Lee1, Mi Kyung Pyo, Jun-Ho Lee, Sun-Hye Choi, Tae-Joon Shin, Sang-Mok Lee, Yoongho Lim, Ye Sun Han, Hyun-Dong Paik, Ssang-Goo Cho, Hye Sook Yun-Choi, Hyewhon Rhim, Seung-Yeol Nah.   

Abstract

Quercetin, one of the flavonoids, is a compound of low molecular weight found in various plants and shows a wide range of diverse neuropharmacological actions. In fruits and vegetables, quercetin exists as monomer- (quercetin-3-O-rhamnoside) (Rham1), dimer- (Rutin), or trimer-glycosides [quercetin-3-(2G-rhamnosylrutinoside)] (Rham2) at carbon-3. In the previous studies, we demonstrated that quercetin inhibits both glycine and 5-hydroxytryptamine type 3, (5-HT3A) receptor channel activities expressed in Xenopus oocytes. However, the effects of quercetin glycosides on glycine and 5-HT3A receptor channel activities are not well known. In the present study, we investigated the effects of quercetin glycosides on the human glycine alpha1 receptor and mouse 5-HT3A receptor channel activities expressed in Xenopus oocytes using a two-electrode voltage clamp technique. In oocytes expressing glycine or 5-HT3A receptors, quercetin- or its glycosides-induced inhibitions on glycine- (IGly) and 5-HT-induced current (I5-HT) were dose-dependent and reversible. Applications of quercetin and its glycosides inhibited IGly in order of quercetin>Rutin> or =Rham1>Rham2. Applications of quercetin and its glycosides inhibited I5-HT in order of Rham2> or =quercetin>Rutin=Rham1. The inhibitions of IGly by quercetin glycosides were non-competitive and voltage-sensitive, whereas the inhibitions of I5-HT by quercetin glycosides were competitive and voltage-insensitive manners. These results also indicate that quercetin glycosides might regulate the human glycine alpha1 and mouse 5-HT3A receptors with differential manners.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379051     DOI: 10.1248/bpb.31.611

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  N-Glucosylation in Corynebacterium glutamicum with YdhE from Bacillus lichenformis.

Authors:  Obed Jackson Amoah; Hue Thi Nguyen; Jae Kyung Sohng
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

Review 2.  Role of Licochalcone A in Potential Pharmacological Therapy: A Review.

Authors:  Meng-Ting Li; Long Xie; Hai-Mei Jiang; Qun Huang; Rong-Sheng Tong; Xiang Li; Xin Xie; Hong-Mei Liu
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

3.  Identification of Glycyrrhiza as the rikkunshito constituent with the highest antagonistic potential on heterologously expressed 5-HT3A receptors due to the action of flavonoids.

Authors:  Robin Herbrechter; Paul M Ziemba; Katrin M Hoffmann; Hanns Hatt; Markus Werner; Günter Gisselmann
Journal:  Front Pharmacol       Date:  2015-07-03       Impact factor: 5.810

4.  Selective potentiation of alpha 1 glycine receptors by ginkgolic acid.

Authors:  Galyna Maleeva; Svetlana Buldakova; Piotr Bregestovski
Journal:  Front Mol Neurosci       Date:  2015-10-29       Impact factor: 5.639

5.  Kampo Medicine: Evaluation of the Pharmacological Activity of 121 Herbal Drugs on GABAA and 5-HT3A Receptors.

Authors:  Katrin M Hoffmann; Robin Herbrechter; Paul M Ziemba; Peter Lepke; Leopoldo Beltrán; Hanns Hatt; Markus Werner; Günter Gisselmann
Journal:  Front Pharmacol       Date:  2016-07-29       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.